WEFTIS
Live / Registered — Registered (as of 25 Mar 2025)
What this means for you
Registered since 25 Mar 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98011526
- Registration number
- 7734945
- Mark type
- Stylized text
- Filed
- 24 May 2023
- Published for opposition
- 27 Feb 2024
- Registered
- 25 Mar 2025
- Attorney of record
- Elizabeth K. Rucki
Goods and services
- Class 005 — Pharmaceuticals: Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
Owner
- Glaxo Group Limited, Stevenage, GB
- Glaxo Group Limited, Stevenage, GB
- Glaxo Group Limited, Stevenage, GB
Prosecution history
- 25 Mar 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 25 Mar 2025 — REGISTERED-PRINCIPAL REGISTER
- 03 Mar 2025 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 28 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Feb 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 03 Dec 2024 — NOTICE OF ALLOWANCE CANCELLED
- 28 Feb 2025 — SOU EXTENSION 1 GRANTED
- 23 Oct 2024 — SOU EXTENSION 1 FILED
- 19 Feb 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 03 Dec 2024 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 03 Dec 2024 — NOTICE OF REVIVAL - E-MAILED
- 03 Dec 2024 — PETITION TO REVIVE-GRANTED
- 03 Dec 2024 — TEAS PETITION TO REVIVE RECEIVED
- 03 Dec 2024 — TEAS DELETE 1(B) BASIS RECEIVED
- 02 Dec 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED